About: Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.61 (+3.14%)
ADIL NASDAQ Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc share price
ADIL price activity
Last Price
$3.610
Change (24hr)
0.11 USD (3.14%)
Volume
24.88K
Volume (4w avg)
-
Open
$3.52
Day Range
$3.52 - $3.61
Previous Close
$3.50
Last Trade
13 Oct, 2:06 pm GMT+0
Delayed
13 Oct, 2:06 pm GMT+0
ADIL price performance
Delayed
13 Oct, 2:06 pm GMT+0
ADIL Market Signals